|
Volumn 21, Issue 11, 2003, Pages 1287-1291
|
The rise of European venture capital for biotechnology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
COST BENEFIT ANALYSIS;
ECONOMIC ASPECT;
EUROPE;
FINANCIAL MANAGEMENT;
GEOGRAPHIC DISTRIBUTION;
PRIORITY JOURNAL;
REVIEW;
UNITED STATES;
BIOTECHNOLOGY;
CAPITAL FINANCING;
ENTREPRENEURSHIP;
EUROPE;
INVESTMENTS;
OWNERSHIP;
|
EID: 0242290923
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt1103-1287 Document Type: Review |
Times cited : (7)
|
References (13)
|